Deutsche Bank’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-407,806
| Closed | -$129K | – | 5733 |
|
|
2018
Q1 | $129K | Buy |
407,806
+407,780
| +1,568,385% | +$609K | ﹤0.01% | 4399 |
|
|
2017
Q4 | $0 | Sell |
26
-114,000
| -100% | -$196K | ﹤0.01% | 5276 |
|
|
2017
Q3 | $164K | Sell |
114,026
-1,762
| -2% | -$2.5K | ﹤0.01% | 3971 |
|
|
2017
Q2 | $186K | Sell |
115,788
-2,610
| -2% | -$5.85K | ﹤0.01% | 3966 |
|
|
2017
Q1 | $401K | Buy |
118,398
+115,525
| +4,021% | +$546K | ﹤0.01% | 3205 |
|
|
2016
Q4 | $14K | Buy |
2,873
+2,006
| +231% | +$34.7K | ﹤0.01% | 4661 |
|
|
2016
Q3 | $20K | Sell |
867
-660
| -43% | -$16.6K | ﹤0.01% | 4539 |
|
|
2016
Q2 | $37K | Buy |
1,527
+515
| +51% | +$14.5K | ﹤0.01% | 4548 |
|
|
2016
Q1 | $29K | Sell |
1,012
-489
| -33% | -$13.3K | ﹤0.01% | 4527 |
|
|
2015
Q4 | $55K | Sell |
1,501
-12,673
| -89% | -$559K | ﹤0.01% | 4357 |
|
|
2015
Q3 | $689K | Buy |
14,174
+6,444
| +83% | +$450K | ﹤0.01% | 3175 |
|
|
2015
Q2 | $532K | Sell |
7,730
-14,567
| -65% | -$674K | ﹤0.01% | 3364 |
|
|
2015
Q1 | $796K | Sell |
22,297
-3,113
| -12% | -$92.1K | ﹤0.01% | 3014 |
|
|
2014
Q4 | $321K | Buy |
25,410
+3,125
| +14% | +$45.4K | ﹤0.01% | 4007 |
|
|
2014
Q3 | $342K | Buy |
22,285
+3,125
| +16% | +$65.8K | ﹤0.01% | 3744 |
|
|
2014
Q2 | $519K | Sell |
19,160
-546
| -3% | -$13.5K | ﹤0.01% | 3442 |
|
|
2014
Q1 | $528K | Sell |
19,706
-3,701
| -16% | -$94K | ﹤0.01% | 3296 |
|
|
2013
Q4 | $574K | Sell |
23,407
-5,017
| -18% | -$129K | ﹤0.01% | 3010 |
|
|
2013
Q3 | $913K | Buy |
28,424
+5,398
| +23% | +$167K | ﹤0.01% | 3045 |
|
|
2013
Q2 | $681K | Buy |
+23,026
| New | +$859K | ﹤0.01% | 2969 |
|
Other funds holding ANTH
Deutsche Bank's ANTH Position: Q2 2018 in Review
Deutsche Bank sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 407,806 shares — an estimated $129K sold.
Deutsche Bank first reported a position in ANTH in Q2 2013 and held it in 20 quarters. The position peaked at $913K in Q3 2013. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.
- Deutsche Bank reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
- Deutsche Bank sold 407,806 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $129K.
- Deutsche Bank first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
- Deutsche Bank's Anthera Pharmaceuticals, Inc. position peaked at $913K in Q3 2013.
- 5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.
Based on Deutsche Bank's 13F filing for Q2 2018, filed 14 Aug 2018.